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Abstract
OBJECTIVE: To investigate the inhibitory and
pro-apoptotic effect of Stellera Chamaejasme L ex-
tract (ESC) in vitro.
METHODS: ESC was first extracted with ethanol,
and then washed using a polyamide column with
60% ethanol. ESC was then decompressively recy-
cled and vacuum dried at room temperature to ob-
tain active fractions. Subsequently, the cytotoxic
and apoptotic effects of ESC on NCI-H157 human
lung cancer cells were determined.
RESULTS: The results showed that ESC was rich in
isomers of Chamaejasminor, neochamaejasmine
and Sikokianin. ESC had significant cytotoxicity
against NCI-H157 cells, with an IC50 of approximate-
ly 18.50 µg·mL-1. ESC caused significant increase in
total apoptotic rate, the activity of caspase 3 and 8,
and Fas protein expression (P<0.05).
CONCLUSION: The inhibitory effect of ESC on
NCI-H157 tumor cells might partly be attributed to
its apoptotic induction through activation of the
Fas death receptor pathway.
© 2012 JTCM. All rights reserved.
Key words: Stellera chamaejasme L; Lung neo-
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INTRODUCTION
Pharmacological screening in vitro is fast, sensitive and
specific, as conditions are easy to control. These advan-
tages play important roles in research of drug activity
screening, toxicity evaluation and in-depth study of cel-
lular and molecular pharmacology. It is particularly im-
portant for early anti-tumor activity screening of plant
extracts or compounds.1 Sulforhodamine B (SRB) is a
protein binding dye, which combines with basic amino
acids of biological macromolecules, causing color
change proportional to live cell protein. This staining
technique has been widely used for testing cell prolifer-
ation and chemosensitivity.2 SRB staining has similar
sensibility compared to other cytotoxicity assays such
as the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) or clonogenic assay. The SRB
assay possesses a colorimetric end point and is nonde-
structive and indefinitely stable. These practical advanc-
es make the SRB assay an appropriate and sensitive as-
say to measure drug-induced cytotoxicity, even on
large-scale application.3 In fact, SRB has been adopted
by the National Cancer Institute of the USA for
large-scale screening of new drugs.4
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Apoptosis is a cell self-destructive process under genet-
ic control.5 A variety of human malignant tumor cells
lose some of the capacity to respond to apoptotic stim-
uli. This phenomenon is most prominent in tumor tis-
sue. As a tumor is the disease not only of abnormal cell
proliferation and differentiation, but also of abnormal
apoptosis,6 enhancing the study of drug-induced apop-
tosis and its mechanism, will provide new ideas and ap-
proaches in the prevention and treatment of cancer. In
1992, Hickman first proposed that inducing apoptosis
of tumor cells could act as the main objective and
means in cancer therapy. Thereafter, inducing tumor
cell apoptosis became a hot topic in international can-
cer treatment research.5 Recent studies have shown that
many active ingredients or extracts from traditional
Chinese medicine can induce apoptosis of tumor
cells.7-10 Deepening investigations have demonstrated
that inducing apoptosis of tumor cells may be an im-
portant target for anti-tumor properties found in tradi-
tional medicines.
The dry roots of Stellera chamaejasme L, known as
"Rui xiang lang du" in Chinese, are believed to possess
a pungent and warm-nature. Their effects are clearing
heat and detoxication, edema alleviation, rot removal,
and myogenicity, and have long been used by the Chi-
nese for the treatment of various tumors. The chemical
composition of the herb includes diterpenoid, lignans,
coumarin and other phenylpropanoids, flavonoids, and
volatile oils.11 Much experimental evidence has also
confirmed that several ingredients (e.g., neochamaejas-
min A and daphnane-type diterpene gnidimacrin) sepa-
rated from Stellera chamaejasme L possess anti-cancer
effects. These effects include an influence on apoptosis
related protein expression (e.g., Fas-procaspase 8-pro-
caspase 3 and p21-procaspase 3), that ultimately in-
duced apoptotic events in tumor cells.12-17 It is suggest-
ed that Stellera chamaejasme L has an important poten-
tial antineoplastic value. Our previous experimental
studies have also shown that extract of Stellera Chamae-
jasme (ESC) significantly inhibited growth of H22 tu-
mor cells in mice.18
In this study, we observed the inhibitory effect of ESC
on the human lung cancer cell line, NCI-H157. We
used the SRB method to determine whether ESC can
induce apoptosis in tumor cells, and also to investigate
the mechanism by which this induction may occur.
MATERIALS ANDMETHODS
Preparation of ESC
Stellera chamaejasme L herbal medicine was extracted
3 times with ethanol and the concentrated liquid (vola-
tile to non-alcohol taste) was washed on a polyamide
column with 60% ethanol, and then decompressively
recycled and vacuum dried at room temperature. The
final compound obtained was ESC.
Analysis of ESC
ESC was dissolved with 1 mL of ethanol. Chromato-
graphic equipment included a Waters Alliance
2695-996 HPLC and Zorbax column (4.6 mm× 250
mm). The mobile phase included acetonitrile, water,
and 1% acetic acid-water. Column temperature was 25°
C, injection volume was 20 l, and detection wavelength
was 290 nm. Gradient separation conditions are shown
in Table 1. Mass spectra conditions incorporated a
Finnigan TSQ mass spectrometer, ESI interface; spray
voltage of 4.5kV, capillary temperature of 320° C,
purge gas 40psi, auxiliary gas 20au, and m/z 120-1400
positive and negative ion scan.
Table 1 Gradient isolation conditions
Time
(min)
0
40
60
65
70
Acetonitrile
(%)
10
50
90
100
100
Water
(%)
80
40
0
0
0
1% acetic
acid-water (%)
10
10
10
0
0
Cell line and culture
NCI-H157 cell line was purchased from the Cell Cul-
ture Center of the Chinese Academy of Medical Scienc-
es (Beijing, China). Cells were grown in RPMI 1640
medium (GIBCO, Grand Island, NY, USA) contain-
ing 10% fetal bovine serum (Hyclone Laboratories, Lo-
gan, UT, USA) and 2 mM of glutamine (Sigma, St.
Louis, MO, USA) in a humidified incubator
(Mco-15AC type, SANYO Electric Co Ltd, Osaka, Ja-
pan) at 37°C in 5% CO2. Cells were split twice weekly
and logarithmic growth cells were selected for experi-
ments.
Cytotoxicity assay
Cells were seeded into 96-well microtiter plates in
100 µL medium at a plating density of approximate-
ly 5000 cells/well. After cells were inoculated, the mi-
crotiter plates were incubated at 37° C in 5% CO2,
95% air and 100% relative humidity for 24 h prior to
the addition of experimental drugs.
Groups were divided into control (only complete medi-
um added), dimethyl sulfoxide (DMSO, final concen-
tration, 0.1% ), 5-fluorouracil (5-FU) injection (final
concentration, 100 µg/mL, Shang Hai XuDong HaiPu
Pharmaceutical Co. Ltd, Shanghai, China), increasing
concentrations of ESC (final concentrations: 12.5, 25,
50, 75, 100 µg/mL). Every group had 4-6 double wells.
ESC was dissolved in DMSO and stored frozen prior
to use. At the time of drug addition, different concen-
trations were thawed and diluted to twice the desired fi-
nal maximum test concentration with complete medi-
um. These ESC dilutions (100 µL) were then added to
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wells already containing 100 µL of medium, resulting
in the required final drug concentration.
Following the addition of ESC, plates were incubated
for a further 48 h. The assay was terminated by adding
cold trichloroacetic acid (TCA). Cells were then fixed
in situ by gently adding 50 µL of cold 50% (w/v)
TCA (final concentration, 10%) and incubated for 1
h at 4°C. Then, 100 µL of sulforhodamine B solution
(SRB; Sigma, St. Louis, MO, USA) at 0.4% (w/v) in
1% acetic acid was added to each well, and plates were
incubated for 10 min at room temperature. After stain-
ing, unbound dye was removed by washing five times
with 1% acetic acid and plates were dried in air. Bound
stain was subsequently solubilized with 10 mM triama
base and the absorbance was read on an automated
plate reader (ELX800 type, BIO-TEX Instruments,
INC, Winooski, VT, USA) at a wavelength of 515 nm.
Inhibition rate (% ) was calculated as follows: Inhibi-
tion rate (%)=1-Mean absorbance of treatment group/
Mean absorbance of vehicle control group. IC50 was cal-
culated using a logistic method.
Flow cytometry assay
Cells (1 mL of 5×105 cells) were inoculated into 6 well
plates. Groups were divided into control, DMSO,
5-FU, and ESC (final concentrations 25, 50, 100 µg/
mL). Each group had 3 double wells. After 24 h incu-
bation, drugs were added to plates and incubated for
another 24 h.
The process for the flow cytometry assay was conduct-
ed according to Annexin V-FITC Apoptosis Detection
Kit protocol (Abcam, Cambridge, UK). Cells were rou-
tinely digested in each well, washed with 500 µL of
PBS and centrifuged at 200 g for 5 min. The superna-
tant was then aspirated, whereupon 100 µL of annex-
in-V-FITC (at 1g/mL in HEPES buffer with 1.8 mM
of CaCl2) was added to the cells and incubated for
5-10 min at room temperature in the dark. Finally, 1
ml of HEPES containing 10 g/ml propidium iodide
was added. Samples were analyzed immediately using
flow cytometry (Becton, Dickinson and Company,
Franklin Lakes, NJ, USA).
Caspase activity assay
The methods used for cell treatment were the same as
those used in the flow cytometry assay.
The activity of caspase 3, 8, and 9 were measured with
caspase assay kits (Chemicon International, Inc., Tem-
ecula, CA, USA). Methods were based on the kit proto-
col. First, a pNA standard curve was generated. 1×106
cells were collected (1500 rpm for 10 min). Cells were
resuspended in 50-500 μL of chilled 1× cell Lysis Buf-
fer. Cells were incubated on ice for 10 minutes and
then centrifuged for 5 minutes in a microcentrifuge
(10,000 × g). Supernatant (cytosolic extract) was trans-
ferred to a fresh tube and put on ice. The protein con-
centration for each sample set was detected. Assay mix-
ture was prepared in a 96-well plate or standard micro-
centrifuge tubes, according to assay kits. Samples were
incubated for 1-2 h at 37oC and read at 405 nm in a
microtiter plate reader. Fold-increase in caspase-3, 8, 9
activity was determined by comparing the optical den-
sity (OD) reading from the induced apoptotic sample
with the level of the uninduced control.
Fas and Fas Ligand ELISA
Cells were prepared as described above. The quantita-
tive detection of Fas and Fas Ligand in cells were deter-
mined with an enzyme ligand immunosorbent assay
kit (R&D Systems, Inc., Emeryville, CA, USA). Brief-
ly, cell supernatant together with 9 × Sample Buffer
(100µL) was added to the corresponding sample well
of the microtiter plate. Plates were incubated at 37oC
for 2 h. After the antigens present in the sample were
bound to the coating antibodies adsorbed to the mi-
crowells, plates were washed with 100 µL of wash buf-
fer for 5 times. Biotinylated antibody (100 μL) was
then added to the microtiter plates and incubated at
37oC for 1 h. Plates were washed again. Conjugated en-
zyme (100 μL) was then added to the wells to bind to
antigens captured by the biotinylated antibody. After
removing unbound conjugated enzyme antibody by
washing, TMB Solution (100 μL) was then added to
each well. After incubation at room temperature in the
dark for 15 minutes, the reaction was stopped by add-
ing 100 µL of Stop Solution, and the absorbance was
measured at 450 nm with a microplate reader (Wells-
can MK3, Helsinki, Finland). Fas and Fas Ligand sam-
ple concentrations were determined on the base of a
standard curve prepared from seven standard dilutions.
All samples were analyzed in duplicate, and the limit of
detection was determined to be 15 pg·mL-1.
Statistical analysis
All results were expressed as mean±SD. One way analy-
sis of variance (ANOVA) with multiple comparison
tests were used. P<0.05 was considered significant. Sta-
tistical tests were performed using SPSS version 12.0
(IBM, Armonk, NY, USA).
RESULTS ANDDISCUSSION
Chinese medicines are made from complex ingredients.
Extracting the active ingredient from Chinese medi-
cines demands a huge workload and it is easy to lose
potential active ingredients during the extracting pro-
cess. Our research experience showed that a mixture of
traditional Chinese medicine often has better efficacy
than a single component compound. We therefore pre-
liminarily adopted a LC-MS method for the analysis of
ingredients within the ESC.
Results showed that ESC was still a mixture of com-
pounds. Figure 1 shows actual analysis of chromato-
grams. Part of the peak components containing the in-
gredients of Chamaechromone, neochamaejasmine and
Sikokianin were identified (Table 2).
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Table 2 Identification of ESC components by mass spec-
trometry
Peak
number
1
2
3
4
5
6
7
8
9
10
11
Time
31.17
31.43
32.75
35.20
35.38
37.60
38.33
40.28
45.15
48.63
54.24
Molecular
Weight
542
542
542
542
542
542
542
556
unknow
570
394
Component
identification results
Chamaechromone
or isomer
Chamaechromone
or isomer
One Isomer of
Chamaejasminor,
neochamaejasmine, etc
One Isomer of
Chamaejasminor,
neochamaejasmine, etc
One Isomer of
Chamaejasminor,
neochamaejasmine, etc
One Isomer of
Chamaejasminor,
neochamaejasmine, etc
One Isomer of
Chamaejasminor,
neochamaejasmine, etc
One Isomer of
Sikokianin A,C, etc
unknow
Chamaejasminor
B or isomer
unknow
In this study, we adopted the SRB assay to determine
the cytotoxicity of ESC. Our study showed that the
SRB method has good sensitivity, stability and repro-
ducibility. SRB results showed that the OD values of
50, 100, 200 µg·mL-1 of ESR decreased greatly com-
pared to the DMSO group (P<0.01). Inhibition rates
from the 50, 100, 200 µg·mL-1 ESC groups were
64.31% , 84.68% and 84.37% , respectively, and the
IC50 of ESC was approximately 18.5µg·mL-1. Accord-
ing to Evaluation Criteria of anti-cancer drugs in vitro
19 (plant extract IC50 < 20 μg/mL, the highest inhibito-
ry rate > 80% ), ESC had strong inhibitory effect
against NCI-H157 cancer cells (Figure 2).
A method proposed in recent years to detect apoptosis
is the Annexin V method. Annexin V selectively binds
the inner membrane phospholipids, phosphatidylserine
(PS). In early apoptosis, PS moves to the cell surface, al-
lowing this important feature of apoptosis to be direct-
ly detected by flow cytometry combined with a green
fluorescent probe FITC-Annexin V. Propidium iodide
(PI) can stain the late apoptotic cells to show red fluo-
rescence.8 We used Annexin V/PI combined double la-
beling to observe the apoptosis percentage of ESC in
NCI-H157 cells.20 Our results showed that the early
apoptosis rate of 25, 50, and 100 µg·mL-1 of ESC were
(3.35±0.83)%, (4.64±0.54)% and (7.38±2.12)%, re-
spectively. The late apoptosis rate of 25, 50, 100µg·
mL-1 of ESC were (10.08±1.96)%, (11.63±0.40)% and
(18.07 ± 1.45)% , respectively. The total apoptosis rate
of 25, 50, 100 µg·mL-1 AESC were (13.43±2.79)% ,
(16.27 ± 0.94)% , and (25.45 ± 3.57)% , respectively.
Compared to the DMSO group, the early, late and to-
tal apoptosis rate of 25, 50, 100µg·mL-1 AESC in-
creased greatly (P<0.05, P<0.01 and P<0.01, respective-
ly). ESC can, therefore, induce the apoptosis of
NCI-H157 cells in vitro (Figure 3).
There are at least two broad pathways that lead to
apoptosis, an "extrinsic" and an "intrinsic" pathway. In
both pathways, signaling results in the activation of a
100
95
90
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70
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60
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Figure 1 Liquid chromatography of ESC
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family of Cys (cysteine) proteases, named caspases. In
general, the extrinsic pathway activates caspase 8 and
the intrinsic pathway activates caspase 9. Finally, both
pathways activate caspase 3 that acts in a proteolytic
cascade to dismantle and remove the dying cells.21In
this study, we used spectrophotometry to detect the ac-
tivities of these caspases. The results showed that the ac-
tivity of caspase 3, and 8 in NCI-H157 cells treated by
ESC were increased greatly (P<0.05 and P<0.01, re-
spectively), compared with the DMSO group. The
growth rates of caspase 3 activity in 25, 50, 100µg·
mL-1 ESC groups were 49.47%, 33.74% and 52.58%,
compared with the DMSO group. The growth rates of
caspase 8 activity in 25, 50, 100 µg·mL-1 of ESC
groups were 64.84%, 67.57% and 47.62%, compared
with the DMSO group. Activity of caspase 9 in
NCI-H157 cells treated by ESC did not change signifi-
ESC(μg/mL)
ESC(μg/mL)
ESC(μg/mL)
Figure 3 Annexin V-FITC staining of apoptosis induced by
ESC in NCI-H157 cancer cells. aP<0.05, bP<0.01, significant
versus control group.
ESC(μg/mL)
B
ESC(μg/mL)
A
Figure 2 Cytotoxicity of ESC against NCI-H157 cancer cells.
(A) Absorbance value of different ESC groups are shown
(mean±SD). (B) Inhibition rates of different concentrations of
ESC were calculated. aP<0.01, significant versus control
group.
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ESC(μg/mL)
ESC(μg/mL)
(pg
/μg
pro
tei
n)
ESC(μg/mL)
(pg
/μg
pro
tei
n)
Figure 5 Influence of ESC on Fas, Fas-L expression and Fas/
Fas-L ratio in NCI-H157 cancer cells
aP<0.05, bP<0.01, significant versus control group.
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)
Figure 4 Changes in activity of caspase 3, 8, and 9 influ-
enced by ESC
aP<0.05, bP<0.01, significant versus control group.
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cantly. These results suggested that ESC induces apop-
tosis in NCI-H157 cancer cells via the extrinsic path-
way (Figure 4).
The Fas (CD95) receptor is a cell surface protein that
mediates apoptotic cell death when triggering by Fas li-
gand (FasL). This interaction causes Fas receptor ho-
mo-oligomerization and this leads to activation of the
caspase cascade (apoptotic extrinsic pathway).22 There
have been multiple reports in the literature measuring
basal levels of Fas and FasL in different neoplasms.
Whereas the proapoptotic role of Fas and FasL are well
known, conflicting data are available concerning the
functionality of these two proteins. The increase of Fas
expression in cancer cells has shown proapoptotic ef-
fects, and the increase of FasL expression in a variety of
tumors has been proposed to play a role in tumor for-
mation and metastasis.23,24 Our results demonstrated
that 50µg·mL-1 of ESC can upregulate Fas expression
in NCI-H157 cells, but had no effect on FasL expres-
sion. Probably, apoptosis was induced by ESC in
NCI-H157 cells through the Fas receptor pathway.
However, this observation needs to be confirmed in fur-
ther studies with a specific Fas inhibitor to determine
whether this effect is indeed through the death recep-
tor Fas pathway.
Fas/FasL ratio can be useful as a dynamic response pre-
dictor in cancer patients following chemotherapy. Clin-
ical data has strongly indicated that an increment of
FasS/FasL ratio after treatment can be an excellent
marker of chemosensitivity in cancer patients. By con-
trast, a decreased ratio after treatment can be a predic-
tor of chemoresistance despite an initial response.24
Our data showed that the Fas/FasL ratio in the 50 and
100 µg·mL-1 groups were greatly increased. The results
suggested that NCI-H157 cancer cells were sensitive to
ESC treatment (Figure 5).
ESC exhibited a high inhibitory effect against
NCI-H157 tumor cells in vitro. This modulatory prop-
erty could be attributed to its activation of the Fas
death receptor pathway and induction of apoptosis.
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